Data · dataset · 2026
<p>Subclinical cases display IgG-SC of higher affinity for DENV1 sE and sE-dimer, and higher frequencies of serotype cross-reactive IgG-SC compared to hospitalized patients.</p>
Listed in UCL Research Data Repository
<p><b>A.</b> DropMap-measured affinity (K<sub>D</sub>) of sE-protein-specific IgG-SC binding in subclinical or hospitalized patients infected with (left) DENV1 or (right) DENV2.
Description
Horizontal bars indicate median and interquartile range. Each dot represents one sE-protein-specific IgG-SC. <i>p</i> values were calculated using Kruskall-Wallis followed by Dunn’s multiple comparison test. ns, not significant; *, p ≤ 0.05; **, p ≤ 0.01.
The dotted line indicates the 30nM affinity limit that discriminates E protein binders from non-binders. <b>B.</b> Proportions of IgG-SC binding to the different sE and/or sE-dimer proteins in both patient groups. Number of patients (n), total number of anti-E protein IgG-SC analyzed and percentages of anti-E protein IgG-SC falling in each category are indicated. <b>C.</b> (Top) Frequencies of IgG-SC binding to sE-dimer of only one serotype or both serotypes in subclinical infected cases.
Read the rest (1 more)
(Bottom) Frequencies of IgG-SC with (orange or brown) detectable or (grey) undetectable binding to sE monomers by DropMap from the IgG-SC binding both serotypes (from the dark blue slice) in subclinical infected cases. Frequencies are shown.</p>
Links
Where it is published
- DOI doi.org/10.1371/journal.ppat.1014552.g004 ↗
DOI / persistent id · from rdr ucl ac uk
Catalogue records · 1
- OAI-PMH record api.figshare.com/v2/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Af… ↗
metadata API · from rdr ucl ac uk
Topics
Provenance · 1 source records, 15 field assertions
| Source | Key | Last seen | Raw |
|---|---|---|---|
| UCL Research Data Repository | oai:figshare.com:article/34050123 | 13 d ago | JSON v1 |
| Field | Assertion | Extractor | Evidence |
|---|---|---|---|
| access_level | source · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | |
| concepts[disease].local:disease:cancer | mapping · rdr ucl ac uk | vocabulary-mapper@1.0.0 | keywords['Cancer'] |
| concepts[field].anzsrc:field:310706 | mapping · rdr ucl ac uk | vocabulary-mapper@1.0.0 | keywords['Virology'] |
| concepts[field].anzsrc:field:320211 | mapping · rdr ucl ac uk | vocabulary-mapper@1.0.0 | keywords['Infectious Diseases'] |
| concepts[field].anzsrc:group:3102 | mapping · rdr ucl ac uk | vocabulary-mapper@1.0.0 | keywords['Computational Biology'] |
| concepts[field].anzsrc:group:3107 | mapping · rdr ucl ac uk | vocabulary-mapper@1.0.0 | keywords['Microbiology'] |
| concepts[field].anzsrc:group:3204 | mapping · rdr ucl ac uk | vocabulary-mapper@1.0.0 | keywords['Immunology'] |
| concepts[field].local:field:chemistry | mapping · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | |
| concepts[field].local:field:earth-environmental | mapping · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | |
| concepts[field].local:field:life-sciences | mapping · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | |
| concepts[field].local:field:medicine-health | mapping · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | |
| description | source · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | /metadata/dc/description |
| license | source · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | /metadata/dc/rights |
| publication_date | source · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | |
| title | source · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | /metadata/dc/title |